Navigation Links
GENova Biotherapeutics signs engagement agreement with PacificWave Partners Limited
Date:9/16/2009

NEW YORK, NY, Sept. 16 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics Inc. ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has signed an engagement agreement with PacificWave Partners Limited ("PacWave") for raising a minimum of USD5m to the company as well as actively look for potential buy-out and/or acquisition targets.

The deal will entail an upcoming visit to the US where the management team will be meeting hedge funds and institutional investors, PacWave is confident that with the strength of the management team as well as the liquidity in the company's stock that financing can be secured within a timely fashion and under very favorable terms.

In addition to the fund raising effort, PacWave will approach a number of major pharma companies which are currently active making acquisitions of smaller biotech companies and position GENova as a potential next acquisition target.

About PacificWave Partners Limited

PacificWave Partners is a privately held international financial advisory firm providing investment banking services to privately-held and publicly-traded micro, small and mid capitalization companies throughout Asia, Europe and North America. PacificWave is headquartered in Copenhagen, Denmark with offices in San Francisco, Los Angeles and New York and specializes in capital raises between USD5m - USD50m

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer, Amgen, Myriad Genetics, Medarex, and Biogen Idec.

Forward Looking Statements

This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business conditions.


'/>"/>
SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GENova and TheraGlass in advanced negotiations
2. GENova Biotherapeutics forming academic partnerships
3. GENova Biotherapeutics signs collaboration agreement with Prime BioResearch
4. GENova Biotherapeutics and Prime BioResearch signs LOI on diabetes and cancer cure
5. GENova gains access to Big Pharma
6. GENova appoints Dr. Wang Chong to Scientific Advisory Board
7. GENova appoints Dr. Philip Gould to Scientific Advisory Board
8. GENova issues clarifying press release
9. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
10. GENova files patent for new breast cancer treatment
11. GENova appoints Director of Asian business development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... Moore ... to communities in east Texas, is launching a regional charity effort to provide ... in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million ...
(Date:8/18/2017)... ... ... The Brian Gifford Agency, an Indiana-based firm providing asset protection and financial ... in a charity drive to provide for at-risk children and teens in the region. ... a nonprofit organization that has offered critical programs to at-risk and foster children in ...
(Date:8/18/2017)... ... 2017 , ... The Golseth Agency, a Texas based insurance management and financial ... regional charity campaign organized to provide support to Christina Upchurch and her two children ... and her children returned from out of town to find her husband passed away ...
(Date:8/18/2017)... Fl (PRWEB) , ... August 18, 2017 , ... ... network of highly trained practitioners specializing in bioidentical hormone replacement therapy and integrative ... with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid disorder ...
(Date:8/18/2017)... ... ... Alcovit, a lime-flavored beverage that rids the body of toxins linked to ... available through Jet.com. , After 25 years of development, the company released its ... quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with friends ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
(Date:8/3/2017)...  Opioid addiction and other drugs of abuse, blood ... threatening outcomes, were problems taken on directly as laboratory ... support them, met this week. This according to Kalorama ... of abuse, procalcitonin and acute kidney injury were key ... meeting in San Diego, CA. ...
(Date:8/2/2017)... -- Life Flight Network and PeaceHealth Oregon Network announced they renewed ... operational efficiency for patients at hospitals in Eugene ... Grove , and Florence, Oregon , ... Network work collaboratively to move patients who require the highest ... sensitive emergency exists. ...
Breaking Medicine Technology: